BridgeMD
New treatment option for Esophageal Cancer
Official title Developing an Ecological and Tailored Nutritional Intervention to Improve Quality of Life in Esophageal Cancer Survivors
ClinicalTrials.gov ID: NCT07024849
What this study is testing
- What it's testing
- This study aims to apply and assess the clinical feasibility of a health behavior theory-based ecological nutrition intervention program, providing nutrition care tailored to the unmet needs of esophageal cancer survivors after surgery. Esophageal cancer survivors will receive a 4-week nutrition intervention program tailored to their individual nutritional needs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with clinical stage 1-3 primary esophageal cancer at diagnosis who have planned or received treatment, including esophageal resection and...
- You are at least 18 years of age
- Have a native-level understanding of Korean
- Who consented to this study
You likely can't join if
- Concurrent multiple cancers at the time of diagnosis or a history of diagnosed and treated other organ cancers within the past year at the time of...
- Have had esophageal resection and reconstruction surgery for other reasons before being diagnosed with esophageal cancer
- Persons with limited cognitive and communication abilities
- The patient has had problems progressing to oral feeding after surgery, requiring a concurrent ileostomy, or the investigator determines that an...
- Individuals with reduced renal function for whom protein intake is not recommended (estimated GFR \<60 mL/min/1.73 m2)
- People who are unable to walk due to joint problems, paralysis, etc.
See the full eligibility criteria
- Patients with clinical stage 1-3 primary esophageal cancer at diagnosis who have planned or received treatment, including esophageal resection and reconstruction, with curative intent, and their families\ .
- You are at least 18 years of age
- Have a native-level understanding of Korean
- Who consented to this study
- Concurrent multiple cancers at the time of diagnosis or a history of diagnosed and treated other organ cancers within the past year at the time of diagnosis
- Have had esophageal resection and reconstruction surgery for other reasons before being diagnosed with esophageal cancer
- Persons with limited cognitive and communication abilities
- The patient has had problems progressing to oral feeding after surgery, requiring a concurrent ileostomy, or the investigator determines that an treatment study is not appropriate.
- Individuals with reduced renal function for whom protein intake is not recommended (estimated GFR \<60 mL/min/1.73 m2)
- People who are unable to walk due to joint problems, paralysis, etc.
- Those who do not use smartphones
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.